ISIN | LU1589327680 |
---|---|
Valor Number | 36494209 |
Bloomberg Global ID | EURCHA SW |
Fund Name | UBS (Lux) Fund Solutions - MSCI Europe UCITS ETF (hedged to CHF) A-acc |
Fund Provider |
UBS Asset Management Switzerland AG
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund aims to track, before expenses, the price and income performance of the MSCI Europe Index (Net Return) (this sub-fund's "Index"). |
Peculiarities |
Current Price * | 4.18 CHF | 17.12.2024 |
---|---|---|
Previous Price * | 4.20 CHF | 16.12.2024 |
52 Week High * | 17.42 CHF | 20.05.2024 |
52 Week Low * | 4.08 CHF | 20.11.2024 |
NAV * | 4.18 CHF | 17.12.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 392,519,477 | |
Unit/Share Assets *** | 41,537,612 | |
Trading Information SIX |
YTD Performance | -73.26% |
29.12.2023 - 17.12.2024
29.12.2023 17.12.2024 |
---|---|---|
1 month | +1.80% |
18.11.2024 - 17.12.2024
18.11.2024 17.12.2024 |
3 months | -1.33% |
17.09.2024 - 17.12.2024
17.09.2024 17.12.2024 |
6 months | -75.28% |
17.06.2024 - 17.12.2024
17.06.2024 17.12.2024 |
1 year | -73.15% |
18.12.2023 - 17.12.2024
18.12.2023 17.12.2024 |
2 years | -70.01% |
19.12.2022 - 17.12.2024
19.12.2022 17.12.2024 |
3 years | -72.04% |
17.12.2021 - 17.12.2024
17.12.2021 17.12.2024 |
5 years | -67.38% |
17.12.2019 - 17.12.2024
17.12.2019 17.12.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novo Nordisk AS Class B | 3.17% | |
---|---|---|
ASML Holding NV | 2.67% | |
SAP SE | 2.46% | |
Nestle SA | 2.04% | |
AstraZeneca PLC | 1.91% | |
Roche Holding AG | 1.86% | |
Shell PLC | 1.81% | |
Novartis AG Registered Shares | 1.80% | |
Lvmh Moet Hennessy Louis Vuitton SE | 1.72% | |
HSBC Holdings PLC | 1.63% | |
Last data update | 13.12.2024 |
TER | 0.13% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.13% |
Ongoing Charges *** | 0.14% |
SRRI ***
|
|
SRRI date *** | 30.11.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |